Cargando…
Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial
The AmbOx trial provides RCT evidence for ambulatory oxygen therapy improving HRQoL in patients with fibrotic ILD http://ow.ly/uHC030nEzsz
Autores principales: | Creamer, Andrew W., Barratt, Shaney L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544787/ https://www.ncbi.nlm.nih.gov/pubmed/31191728 http://dx.doi.org/10.1183/20734735.0002-2019 |
Ejemplares similares
-
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial
por: Visca, Dina, et al.
Publicado: (2017) -
Ambulatory management of primary spontaneous pneumothorax
por: Duffy, Aleksandra, et al.
Publicado: (2021) -
Does high-flow oxygen reduce escalation of care in infants with hypoxaemic bronchiolitis?
por: Mozun, Rebeca, et al.
Publicado: (2019) -
Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
por: Suarez-Cuartin, Guillermo, et al.
Publicado: (2019) -
Quality of life assessment in clinical research on Chinese medicine: Early experience and outlook
por: Wong, Lai Yi Eliza, et al.
Publicado: (2008)